Literature DB >> 17221307

Vasoactivity of blood vessels using a novel isovolumic myograph.

Xiao Lu1, Ghassan S Kassab.   

Abstract

The vasoactivity of blood vessel is impaired by cardiovascular disease. The ex-vivo measurements of vasoactivity (wire and pressure myographs) have some inherent difficulties in the characterization of pharmacodynamics and biomechanics. Here, we introduce a novel isovolumic myograph which allows simultaneous measurement of both dynamic pressure and dimensional changes during vasoconstriction or vasodilation. The principle of the isovolumic myograph is based on the utility of a hydraulically closed system with low compliance such that contraction against an incompressible fluid increases the pressure with the closed system while dilation decreases it. We demonstrate the sensitivity and utility of the new technique by the response of elastic (carotid), muscular (femoral) arteries, and femoral veins. The results show characteristic dynamic pressure response for each vessel type. Furthermore, our results show a Hill-type equation for the tension-velocity relation for smooth muscles as well as characteristic curves for each contraction. These novel findings for blood vessels will advance our knowledge of endothelium and vascular smooth muscle mechanics and pharmacodynamics.

Entities:  

Mesh:

Year:  2007        PMID: 17221307     DOI: 10.1007/s10439-006-9243-0

Source DB:  PubMed          Journal:  Ann Biomed Eng        ISSN: 0090-6964            Impact factor:   3.934


  12 in total

1.  SWI/SNF complexes containing Brahma or Brahma-related gene 1 play distinct roles in smooth muscle development.

Authors:  Min Zhang; Meng Chen; Ju-Ryoung Kim; Jiliang Zhou; Rebekah E Jones; Johnathan D Tune; Ghassan S Kassab; Daniel Metzger; Shawn Ahlfeld; Simon J Conway; B Paul Herring
Journal:  Mol Cell Biol       Date:  2011-04-25       Impact factor: 4.272

2.  Biaxial vasoactivity of porcine coronary artery.

Authors:  Yunlong Huo; Yana Cheng; Xuefeng Zhao; Xiao Lu; Ghassan S Kassab
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-16       Impact factor: 4.733

3.  Assessment of endothelial function of large, medium, and small vessels: a unified myograph.

Authors:  Xiao Lu; Ghassan S Kassab
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-11-12       Impact factor: 4.733

4.  Reactive oxygen species cause endothelial dysfunction in chronic flow overload.

Authors:  X Lu; X Guo; C D Wassall; M D Kemple; J L Unthank; G S Kassab
Journal:  J Appl Physiol (1985)       Date:  2010-12-02

Review 5.  Microstructure-based biomechanics of coronary arteries in health and disease.

Authors:  Huan Chen; Ghassan S Kassab
Journal:  J Biomech       Date:  2016-03-20       Impact factor: 2.712

6.  Elevated oxidative stress and endothelial dysfunction in right coronary artery of right ventricular hypertrophy.

Authors:  Xiao Lu; Charles Q Dang; Xiaomei Guo; Sabee Molloi; Cynthia D Wassall; Marvin D Kemple; Ghassan S Kassab
Journal:  J Appl Physiol (1985)       Date:  2011-03-17

7.  Microstructural constitutive model of active coronary media.

Authors:  Huan Chen; Tong Luo; Xuefeng Zhao; Xiao Lu; Yunlong Huo; Ghassan S Kassab
Journal:  Biomaterials       Date:  2013-07-13       Impact factor: 12.479

8.  Rosiglitazone reverses endothelial dysfunction but not remodeling of femoral artery in Zucker diabetic fatty rats.

Authors:  Xiao Lu; Xiaomei Guo; Sotirios K Karathanasis; Karen M Zimmerman; Jude E Onyia; Richard G Peterson; Ghassan S Kassab
Journal:  Cardiovasc Diabetol       Date:  2010-05-19       Impact factor: 9.951

9.  Distension-induced gastric contraction is attenuated in an experimental model of gastric restraint.

Authors:  Xiao Lu; Xiaomei Guo; Samer G Mattar; Jose A Navia; Ghassan S Kassab
Journal:  Obes Surg       Date:  2010-11       Impact factor: 4.129

10.  Protein kinase C inhibition ameliorates functional endothelial insulin resistance and vascular smooth muscle cell hypersensitivity to insulin in diabetic hypertensive rats.

Authors:  Xiao Lu; James S Bean; Ghassan S Kassab; Mark D Rekhter
Journal:  Cardiovasc Diabetol       Date:  2011-06-02       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.